Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 260Carcinoma, Non-Small-Cell Lung 125Glioblastoma 105Breast Neoplasms 104Ovarian Neoplasms 96Carcinoma, Hepatocellular 88Brain Neoplasms 71Rectal Neoplasms 69Neoplasm Metastasis 69Lung Neoplasms 65Colonic Neoplasms 58Neoplasms 57Glioma 52Fallopian Tube Neoplasms 44Carcinoma, Renal Cell 36Gliosarcoma 31Pancreatic Neoplasms 30Melanoma 27Liver Neoplasms 26Stomach Neoplasms 21Astrocytoma 21Adenocarcinoma of Lung 21Recurrence 20Kidney Neoplasms 19Colorectal Cancer Metastatic 17Triple Negative Breast Neoplasms 16Esophageal Neoplasms 15Uterine Cervical Neoplasms 14Sarcoma 13Prostatic Neoplasms 13

Interventions

TIC10 compound 1Sorafenib 1Radiosurgery 1Pemetrexed 1Imatinib Mesylate 1Cyclophosphamide 1Biopsy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Unspecified Adult Solid Tumor × Bevacizumab × Clear all
NCT00390156 2020-07-28

Imatinib, Bevacizumab, and Cyclophosphamide in Patients With Refractory Metastatic Solid Tumors

University of California, San Francisco

Phase 1 Completed
35 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡